TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2019

Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study.

Vikas Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.